NEWS FLASH

Atland buys Sienna Real Estate

Atland, headquartered in Paris, has agreed to acquire 100 per cent of Sienna Real Estate from its shareholder Groupe Bruxelles Lambert, adding a pan‑European real estate platform with around 80 staff based in France, Germany, the Netherlands, Spain, the UK and South Korea, and taking the combined platform beyond €10 billion of assets under management.

The group already manages more than €600 million of assets outside France and is using its SCPI range to push into pan‑European strategies, including a new healthcare and life sciences vehicle.

Atland has rolled out Épargne Pierre Sophia, billed as a SCPI dedicated to healthcare and life sciences, targeting clinics, medical centres, pharmacies, laboratories and care facilities, primarily in the eurozone with selective exposure to the UK and Switzerland. In Ireland, Atland paid €7.2 million for Building 1 at Parkmore West Business Park in Galway, a 5,751 sq m manufacturing facility fully let to Celestica on a lease running to July 2030.

Sienna brings complementary expertise in the sector. In the Netherlands, Sienna Real Estate has advised Novaxia Investissement on acquiring the D.O.R.C. complex in Zuidland near Rotterdam, a 10,200 sq m business property with extensive clean‑room and laboratory facilities fully let to Dutch Ophthalmic Research Center, which develops and produces medical instruments and equipment for ophthalmic surgery.

Sienna’s Benelux team has also advised SCPI Transitions Europe on acquiring a bioanalytical laboratory in Assen with about 5,650 sq m of lettable space, built in 2015 and expanded in 2020, now fully let to ICON, the clinical research organisation.

Taken together, the Atland–Sienna tie‑up creates a cross‑border investor with life sciences credentials spanning laboratories, production facilities and a growing portfolio of healthcare assets.